#alzheimer
#amyloid
Amazing new paper from @sfackley.bsky.social that exposes the statistical alchemy Lilly applied to their donanemab data:
jamanetwork.com/journals/jam...
There is little to no correlation between amyoid removal and clinical outcomes with donanemab (or lecanemab).
#alzheimer
#amyloid
Amazing new paper from @sfackley.bsky.social that exposes the statistical alchemy Lilly applied to their donanemab data:
jamanetwork.com/journals/jam...
There is little to no correlation between amyoid removal and clinical outcomes with donanemab (or lecanemab).
Our response now out in JAMA Neurology: they are.
jamanetwork.com/journals/jam...
www.theguardian.com/commentisfre...
2) A covariate that is not predictive of outcome should not be in the model, even if predictive of assignment.
3) The propensity score is stupid.
2) A covariate that is not predictive of outcome should not be in the model, even if predictive of assignment.
3) The propensity score is stupid.
alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
https://sherwood.news/tech/openai-claimed-a-math-breakthrough-this-weekend-only-to-be-smacked-down/
📈 TIME-AD’s latest paper, led by Dr. Sarah Ackley, examines 20,000+ abstracts using an LLM to determine whether P value trends reflect changes in p-hacking, publication bias, or statistical power.
Read it: tinyurl.com/3f3nuxma
📈 TIME-AD’s latest paper, led by Dr. Sarah Ackley, examines 20,000+ abstracts using an LLM to determine whether P value trends reflect changes in p-hacking, publication bias, or statistical power.
Read it: tinyurl.com/3f3nuxma
I gather we've passed the point where there are now more systematic reviews of RCTs than original RCTs.
What a wonderful achievement for humankind.